Lycia Therapeutics is the operator of a biotechnology firm that aims to research and produce first-in-class therapies. The company's lysosomal targeting chimeras (LYTACs) platform is used to develop therapeutics that degrade extracellular and membrane-bound proteins that drive a variety of difficult-to-treat diseases, such as cancer and autoimmune conditions, allowing doctors to obtain drugs to cure patients.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
65
Frequently Asked Questions
What is Market Cap of Lycia Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Lycia Therapeutics Inc. market cap is $1.56B.
What is the 52-week high for Lycia Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lycia Therapeutics Inc. 52 week high is $36.49 as of October 25, 2026.
What is the 52-week low for Lycia Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lycia Therapeutics Inc. 52 week low is $18.00 as of October 25, 2026.
What is Lycia Therapeutics Inc. stock price today?
Lycia Therapeutics Inc. stock price today is $30.00.
What was Lycia Therapeutics Inc. stock price yesterday?
Lycia Therapeutics Inc. stock price yesterday was $18.00.
What is the 50-day moving average of Lycia Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Lycia Therapeutics Inc. 50-day moving average is $24.00.
How many employees does Lycia Therapeutics Inc. have?